FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pentamidine Isethionate (Nebupent) For Inhalation Solution
Status: Currently in Shortage
»Date first posted: 08/02/2019
»Therapeutic Categories: Anti-Infective

Fresenius Kabi USA, LLC (Revised 08/23/2019)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
300 mg per vial, SDV, PF (NDC 63323-877-15) Available Check wholesalers for inventory Manufacturing delays

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English